Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib + mFOLFOX-6 in Metastatic Pancreatic Cancer
NCT01489865Phase 2Completed
- Sponsor
- Georgetown University
- Start
- Jan 2011
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of veliparib in pancreatic adenocarcinoma (PDAC), sponsored by Georgetown University. Started Jan 2011; status: completed.
02
Drugs
veliparib
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01489865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01489865.